Brief: Cara Therapeutics Q4 revenue USD 3.261 million
06/03/2023 21:36
Mar 6 (Reuters) - Cara Therapeutics Q4 net income USD -30.339 million. * Q4 operating income USD -31.307 million * Q4 operating expenses USD 34.568 million * Q4 revenue USD 3.261 million
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM